Your browser doesn't support javascript.
loading
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Souquet, Pierre-Jean; Audigier-Valette, Clarisse; Molinier, Olivier; Cortot, Alexis; Margery, Jacques; Moreau, Lionel; Gervais, Radj; Barlesi, Fabrice; Pichon, Eric; Zalcman, Gérard; Dumont, Patrick; Girard, Nicolas; Poudenx, Michel; Mazières, Julien; Cadranel, Jacques; Debieuvre, Didier; Dauba, Jérôme; Langlais, Alexandra; Morin, Franck; Moro-Sibilot, Denis; Westeel, Virginie; Pérol, Maurice.
Affiliation
  • Souquet PJ; Department of Pneumology, Hôpital Lyon Sud - Lyon, France. Electronic address: pierre-jean.souquet@chu-lyon.fr.
  • Audigier-Valette C; Department of Pneumology, CHITS Sainte Musse - Toulon, France.
  • Molinier O; Service des Maladies Respiratoires, Centre Hospitalier Général - Le Mans, France.
  • Cortot A; Thoracic Oncology Department, CHU Lille, Univ. Lille, Siric ONCOLille, CNRS UMR8161, Lille F-59000, France.
  • Margery J; Department of Pneumology, Hôpital D'Instruction des Armées Percy, Clamart, France.
  • Moreau L; Department of Pneumology, Hôpital Louis Pasteur, Hôpitaux Civils de Colmar, Colmar, France.
  • Gervais R; Department of Pneumology, Centre François Baclesse, Caen, France.
  • Barlesi F; Aix Marseille University, CNRS, INSERM, CRCM, APHM, Campus Timone, CHU NORD, Chemin des Bourrely, Marseille 13915, France; Gustave Roussy cancer campus - Villejuif, France.
  • Pichon E; Department of Pneumology, CHRU Bretonneau, Tours, France.
  • Zalcman G; University Hospital Bichat Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris-Diderot University Paris, France.
  • Dumont P; Hospital Centre - Chauny, France.
  • Girard N; Institut Curie Montsouris Thorax, Institut Curie, Paris, France.
  • Poudenx M; Department of Oncology, CRLCC - Nice, France.
  • Mazières J; Department of Pneumology, Hôpital Larrey - Toulouse, France.
  • Cadranel J; Department of Pneumology and Thoracic Oncology, Hôpital Tenon, Assistance Publique Hôpitaux de Paris and GRC 04 Theranoscan Sorbonne Université, Paris, France.
  • Debieuvre D; GHRMSA, Mulhouse, France.
  • Dauba J; Departement of Oncology, Hôpital Mont de Marsan - Mont-de-Marsan, France.
  • Langlais A; Intergroupe Francophone de Cancérologie Thoracique - Paris, France.
  • Morin F; Intergroupe Francophone de Cancérologie Thoracique - Paris, France.
  • Moro-Sibilot D; Thoracic Oncology Unit, PTV, CHU Grenoble-Alpes CS10217, 38043 Grenoble, France.
  • Westeel V; Université de Bourgogne-Franche Comté, INSERM UMR 1098, University Hospital Jean Minjoz, Department of Pneumology, Besançon, France.
  • Pérol M; Cancer Research Centre Léon-Bérard, Lyon, France.
Lung Cancer ; 164: 84-90, 2022 02.
Article in En | MEDLINE | ID: mdl-35051725

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: